| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Imeka We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters. Imeka is currently the only company to combine diffusion imaging and AI to map white matter integrity and get insights on neuroinflammation, demyelination and axonal loss. Therefore, with our non-invasive technology, we minimize risks for our pharma and biotech clients in the development of treatments for neurodegenerative diseases. Imeka’s main goal is to play an influential role in the search and development of cures for brain disease. Imeka’s diffusion imaging tools are able to measure extracellular water fraction (free-water), which is sensitive neuroinflammation. The technology … Type: | 3 | 1 | 1 | 17 |
 | eNUVIO - Microfabricated Devices for Next-generation Cell Culture Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These … Type: | 1 | 1 | 0 | 5 |
 | Tilray Brands, Inc. A lifestyle company leading the intersection of cannabis, craft beverage, and hemp industries. Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over … Type: | 3 | 0 | 3 | 988 |
 | MORSE Consulting Inc. Deciphering pharmaceutical market access signals to create reimbursement success. Established in January 2017, Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc’s vision is to be a leader in strategic pharmaceutical reimbursement consulting with a reputation for honesty, integrity, and collaboration. With a presence in both Toronto and Ottawa, MORSE seeks to effectively understand our client’s challenges and develop viable strategies to navigate the market access landscape. MORSE offers a range of services related to both negotiation and reimbursement strategies. Reimbursement Risk Appraisal, Market Access Appraisal, Advisory Boards, Private Payer PLA Strategy, PLA Seminar, Negotiation "Revitalization", Ongoing Strategic Advice, Reimbursement … | 3 | 0 | 2 | 15 |
 | Winterlight Labs Monitoring cognitive impairment through speech Like a lighthouse providing early warning in the dark of night, changes in language can signal cognitive decline decades before symptoms of dementia become apparent. Currently, over 47.5 million individuals in the world have dementia, and that number is expected to triple by 2050. At WinterLight Labs, we build technology that can quickly and accurately detect signs of cognitive impairment from a sample of speech. A short 1-5 minute snippet of speech can paint a picture about the speaker's cognitive state, including lexical diversity, syntactic complexity, semantic content, and acoustics. The technology can detect the … Type: | 5 | 0 | 2 | 27 |
 |  SPOTMYUV SPOTMYUV is your SPF’s new BFF! 💜 One sticker works all day to show you when to re-apply your sunscreen.☀️ #GetSpotted SPOTMYUV® is the world's first clinically proven UV Detection Sticker that gives you a personalized reminder of when it's time to reapply your sunscreen. As you run, swim, sweat, and play, SPOTMYUV's® patented DermatrueTM skin mimicking technology interacts with sunscreen like your skin, giving you a clear view of your sun protection in real time. Nanotechnology, Sun Care, Cosmetics, Consumer Packaged Goods, beauty, skincare, and SPF Type: | 4 | 0 | 1 | 1 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: | 0 | 0 | 0 | 16 |
 | ImpriMed, Inc. AI-driven Personalized Medicine for Cancer Care ImpriMed, founded in 2017 in Silicon Valley, is a leading precision medicine startup revolutionizing cancer treatment with artificial intelligence. The company’s pioneering drug response prediction technology helps reduce costs, accelerate treatment, enhance efficacy, and improve the quality of life for patients. To date, the company’s technology has been deployed across more than 40 U.S. states, and 17,000+ canine and feline blood cancer tests have been performed as of 2024. ImpriMed is now poised to extend its groundbreaking AI-driven approach to human healthcare, redefining the future of oncology treatment with personalized, effective solutions. For additional … Type: | 1 | 0 | 1 | 41 |
 | ELIAS Animal Health Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com. Type: | 0 | 0 | 0 | 11 |
 | Loyal Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to … Type: | 0 | 0 | 0 | 210 |
 |  TerrAscend A leading North American cannabis operator TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan, and California and retail operations in Canada. TerrAscend operates The Apothecarium, Gage, and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera … Type: | 1 | 0 | 1 | 370 |
 | Telo Genomics Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for … Type: | 0 | 0 | 0 | 14 |
 | Streamline Genomics Democratizing precision medicine Streamline Genomics is developing a platform to help clinicians and researchers benefit from genomic sequencing without the need for data analysis expertise. Type: | 4 | 1 | 3 | 2 |
 | FREDsense Technologies Fastest provider of PFAS sample analysis in the lab and field. FREDsense is the fastest provider of PFAS sample analysis in the lab and field helping developers, operators, and consultants expand screening programs, optimize destruction and remediation efforts, and accelerate PFAS mitigation efforts globally. We apply our decade’s worth of innovative rapid test development for hard-to-detect compounds and parameters and using the power of biology, quickly and affordably help organizations understand exactly what’s in their water. Synthetic Biology, Water Quality Monitoring, Cleantech, Biotechnology, Sensors, Instrumentation, IoT, PFAS, and Analytical Testing Type: | 0 | 0 | 0 | 26 |
 | conversationHEALTH As of January 8, 2024, conversationHEALTH has joined forces with Swoop (www.swoop.com), revolutionizing patient and provider engagement throughout the healthcare industry. This strategic partnership combines conversationHEALTH's expertise in developing advanced conversational AI solutions with Swoop's proficiency in creating precise DTC and HCP audiences. Together, we aim to deliver an unparalleled engagement solution that offers real-time, personalized interactions for patients and healthcare providers, allowing pharmaceutical brands to seamlessly connect with customers and meaningfully transform their websites. Stay tuned as we embark on this journey to reimagine healthcare communication, enhancing user experience and driving positive patient outcomes. Please follow along at Swoop … Type: | 12 | 3 | 9 | 24 |
 | Treventis Corporation TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology … Type: | 1 | 1 | 0 | 16 |
 | ACTO Field Force Effectiveness in Biopharma ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for Life Sciences that helps Sales, Marketing, and Medical teams improve customer engagement and brand performance by turning field professionals into “Masters of the Message” who engage HCPs and their support teams with authority and impact. With ACTO, #Biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness. Intelligent Field Excellence, Artificial Intelligence, Sales Enablement, Sales … Type: | 11 | 1 | 9 | 99 |
 | MetaOptima Technology Inc. Intelligent Dermatology | Striving to empower patients & care providers with innovative tools for better care outcomes. MetaOptima: empowering users with advanced technologies MetaOptima is a digital health tech company dedicated to revolutionizing the dermatology and skin care industry with affordable, effective and intelligent tools. In order to provide state-of-the-art care, both medical professionals and their patients should be equipped with advanced tools. We are proud to offer two products designed to enhance the quality of patient care and organization while streamlining services for maximum efficiency: DermEngine and MoleScope. DermEngine is an intelligent skin analytics platform designed to provide medical … Type: | 2 | 0 | 2 | 29 |
 | MediPharm Labs MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, … Type: | 0 | 0 | 0 | 143 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … Type: | 1 | 1 | 1 | 26 |
 | ThePowerHouse We are shaping the Future of the Creative Industries with Disruptive Education, Future Thinking & Strategic Innovation ThePowerHouse is a leading innovation agency for FashionTech and wearable technology. We’re an interdisciplinary team consisting of creative technologists, makers, and fashion designers. Our work encompasses rapid prototyping, consulting, matchmaking and education. We love taking on challenges and ideas that have never been created before. We love pushing the boundaries of the status quo and designing for the future. ThePowerHouse GmbH is part of EC Brands. IOT, SmartTextiles, Industry4.0, Digital, Innovation, Design Thinking , WearableTechnologies, Mobility, FashionTech, Interactivity , SmartFashion, Rapid Prototyping, Sensor … Type: | 1 | 0 | 1 | 2 |
 | OncoDNA OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker … Type: | 10 | 3 | 6 | 49 |
 | Cellaïon Cell Signaling Technology for Organ Repair and Regeneration Cell Signaling Technology for Organ Repair and Regeneration We care for liver Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology Type: | 2 | 1 | 1 | 26 |
 | Kura Oncology, Inc. Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib is a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction for the treatment … Type: | 0 | 0 | 0 | 220 |
 | Gritstone bio A clinical-stage biotech company that aims to develop the world’s most potent vaccines for cancer and infectious disease Gritstone bio brings together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to develop the next-generation of vaccines for cancer and infectious disease. With our unique approach to immuno-oncology and infectious diseases, we seek to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens. We started with a focus on tumor-specific neoantigens and … Type: | 0 | 0 | 0 | 139 |
 | Cellarity Rewriting the rules of drug creation Cellarity is fundamentally redesigning the way drugs are created. By shifting the focus from a single target to the underlying cellular dysfunction, the company unravels the complexity of disease biology to create medicines that are out of reach with the target-based drug discovery approach. Founded by Flagship Pioneering in 2017, Cellarity has developed a platform that utilizes proprietary AI models trained on over 30 million single cell transcriptomes to uncover novel actionable biology and create non-intuitive drug candidates in a vast array of diseases. The company currently has programs ongoing in several disease areas … Type: | 3 | 0 | 3 | 134 |
 | Ansa Biotechnologies, Inc. High-fidelity DNA synthesis using enzymes At Ansa Biotechnologies, we’re developing a way to synthesize DNA that will accelerate innovation in medicine, agriculture, and industrial biotechnology. Our fast, clean, and accurate enzymatic DNA synthesis process can produce gene-length molecules directly, overcoming bottlenecks of traditional DNA synthesis methods. We envision a future where our technology empowers scientists to develop solutions for the world's biggest problems in health and sustainability. Note that Ansa does not conduct any employment discussions via LinkedIn. All official Ansa career openings are exclusively listed on our website careers page. DNA | 0 | 0 | 0 | 82 |
 | Camena Bioscience Unlocking access to genes with unparalleled accuracy Our mission is to enable synthetic biologists, by using our technology to unlock access to genes with unparalleled accuracy. We produce genes for a range of biotechnology customers including those in the pharmaceutical, agriculture and diagnostics sectors. Our technology offers access to long and complex gene sequences, which are normally difficult to produce. We are based in Cambridge UK, but we serve companies across the world. Camena's technology is positioned to enable researchers and the synthetic biology revolution. Twitter: @camenabio DNA synthesis, Complex genes, Synthetic Biology, synbio, and Gene synthesis Type: | 1 | 0 | 1 | 32 |
 | Ribbon Bio Making The Impossible Possible We are redefining scientific possibility with our algorithm-driven technology that produces pristine synthetic DNA molecules, enabling our partners to deliver a new generation of transformative solutions for the health of people and planet. Type: | 0 | 0 | 0 | 50 |
 | Nuclera Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology … Type: | 7 | 1 | 4 | 131 |
 | Syncath Neuroscience Multimodal diagnostic and therapeutic platform for the Neuro ICU Syncath Neurosience is focused on diagnostics and therapeutics for brain edema and elevated intracranial pressure such as in traumatic brain injuries, subarachnoid hemorrhage and intracranial hemorrhage Type: | 0 | 0 | 0 | 2 |
 | Synchron Brain Computer Interface Synchron is developing implantable neurotechnology to unlock the brain and solve unmet medical needs at scale brain computer interface, neuroprosthesis, neuromodulation, neuromonitoring, neurotechnology, medtech, biotech, machine learning, and signal processing Type: | 6 | 2 | 4 | 134 |
 | Cartesian Therapeutics Pioneering RNA cell therapy for autoimmune disease Cartesian Therapeutics is a clinical-stage company pioneering mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a potential first-in-class mRNA CAR-T in Phase 2b clinical development for patients with generalized myasthenia gravis and Phase 2 development for systematic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-BCMA mRNA CAR-T. For more information, please visit www.cartesiantherapeutics.com Immunotherapy, Oncology, Molecular Biology, Immunology, Autoimmune Diseases, Myasthenia Gravis, ARDS, Cell Therapy, Lung disease, NETs, Cardiovascular Disease, … Type: | 0 | 0 | 0 | 59 |
 | SIRNAOMICS Sirnaomics is an RNA therapeutics biopharmaceutical company that focuses on the discovery and development of innovative drugs for indications with unmet medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both Asia and the United States. Based on its proprietary delivery technologies, a polypeptide nanoparticle RNAi platform and GalNAc RNAi platform, GalAheadTM, Sirnaomics has established an enriched drug candidate pipeline. STP122G, which represents the first drug candidate utilizing the Group's GalAheadTM mxRNA technology, is currently in Phase I development. STP125G is the second siRNA therapeutics based on Sirnaomics proprietary … Type: | 0 | 0 | 0 | 40 |
 | Biomica Ltd. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics. Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing Evogene's Computational Predictive Biology (CPB) platform. Type: | 1 | 0 | 0 | 22 |
 | Oisin Biotechnologies Genetic medicines for age-related diseases Oisin Biotechnologies is a longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. When cells detect that they have been irreversibly damaged, they enter a non-dividing condition known as cell-cycle arrest, or senescence. It’s believed this occurs to prevent cells from going rogue and turning cancerous. Ideally, they should die by the process known as apoptosis, but as we age, more and more frequently they don’t. They become zombie cells – unable to kill themselves or resume normal function. Senescent cells secrete molecules that cause inflammation in … Type: | 1 | 0 | 1 | 17 |
 | BioAge Labs We are harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. BioAge is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. Our proprietary platform, which encompasses >65M molecular measurements spanning 45+ years of human aging, unlocks a universe of novel biological insights and druggable mechanisms for age-related disease. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults. Azelaprag has the potential as … Type: | 6 | 1 | 5 | 93 |
 | cellvie Levearging the therapeutic potential of mitochondria cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria Transplantation, an approach for mitochondria augmentation and replacement, was developed by Dr. James McCully at Harvard Medical School. cellvie was founded to take this technology from bench to bed, starting in heart attacks and solid organ transplantation. Therapeutic Mitochondria Transfer, Mitochondria, Ischemia-Reperfusion Injury, and Solid Organ Transplantation Type: | 2 | 0 | 2 | 11 |
 | Itris Automation Itris Automation, a Schneider Electric company, is a software engineering company that provides development tools for the verification, conversion and documentation of PLC codes to complement the programming tools of international PLC vendors. As PLC programs become bigger and more complex, the need to ensure their quality and maintain them at the lowest possible cost has never been greater. Thanks to their advanced technologies, Itris Automation supports their customers, whether project managers, developers, quality managers, or industry experts, in improving their development processes and therefore in delivering higher quality programs in shorter timeframes. With a team that is known for … Type: | 1 | 0 | 1 | 6 |
 | Oncoelectronics Inventing a future without cancer using flexible bioelectronics. Inventing a future without cancer using flexible bioelectronics. | 3 | 3 | 0 | N/A |
 |  Spinleap We leverage the most advanced technologies to improve patients' life. Why Spinleap? The world is changing faster than ever. Technologies are disrupting business models at an accelerating pace. Healthcare is reaching a turning point. Spinleap is Ipsen’s answer to this new need for speed and agility. Our Missions *Acceleration: we accelerate high value internal projects by using technology. *Open Innovation: we partner with academics & tech startups to build win/win innovative products. *Disruption: we explore and test emerging technologies to create new ways to improve patients’ life. Contact us We are looking for experts on any relevant technology (IoT, AI, … Type: | 3 | 1 | 0 | 1 |
 | Rhenovia Pharma RHENOVIA Pharma is a French biotech company founded in 2007 by an international team comprising executives of the big pharmaceutical industry and world experts in the fields of neurosciences and modeling of the nervous system. In less than 5 years, Rhenovia became a biosimulation world leader in CNS. Its worldwide unique modeling technology makes it possible to reproduce on computers the cellular and molecular mechanisms of the brain and the neuronal transmission. Rhenovia uses its technology to create computational models that simulate the condition of healthy persons or affected by pathologies of the nervous system (Alzheimer, Parkinson, epilepsy, schizophrenia, depression). … Type: | 0 | 0 | 0 | 3 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Computational Chemistry, Molecular Dynamics Simulation, Quantum Physics, Drug Discovery, Drug Design, Quantum Computing, Quantum Chemistry, and HPC Tags: FrenchTech2030 Type: | 57 | 17 | 48 | 65 |
 | mYXpression Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence … Type: | 22 | 4 | 21 | 5 |
 | MilliDrop Every Droplet Counts Harnessing its millifluidic technologies, MilliDrop develops and markets systems for microbiology applications that incubate, analyze and handle thousands of hundred-nanoliter-scale samples in parallel. Given the Analyzer’s compact nature, the effectiveness of dropletbased cultivation, and the option of integrating this technology into an automated process, MilliDrop can meet the needs in three segments of the global biological instrument and reagent market : Research, Industrial microbiology & Diagnostic À partir de ses technologies millifluidiques, MilliDrop développe et commercialise des automates pour la microbiologie qui permettent d’incuber, d’analyser et de manipuler des milliers d’échantillons d’une centaine de nanolitres en parallèle. … Type: | 6 | 3 | 4 | 91 |
 | Loop Dee Science Tests you can trust ! Making molecular biology faster and more accessible! Founded in 2017 and based in Caen in Normandy, Loop Dee Science is a DNA expert start-up that makes molecular biology diagnostics more accessible to as many users as possible. Our expertise is based on the use of amplification technology and the creation of tools to automate these tests. We develop and manufacture rapid, reliable and simple genetic analysis kits for use in the field to detect pathogen DNA and RNA. Biologie moléculaire, Kits d'analyses terrain, Kits vétérinaire, Recherche et développement, and PCR Type: | 8 | 3 | 5 | 12 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 0 | 2 | 2 |
 | INNOVHEM Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. Type: | 13 | 4 | 10 | 4 |
 | InFlectis BioScience Developpment of small molecules to prolong the protective effect of the Integrated Stress Response InFlectis BioScience is a private clinical-stage company aiming to target and modulate interactions between proteins involved in key human pathophysiological processes. The company is developing IFB-088 (INN: icerguastat), which specifically targets the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of diseases affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation. … Type: | 2 | 2 | 0 | 9 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 31 |
 | Olgram marine-inspired molecules to fight immunological diseases Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-depression after traumatic brain injury and concussion. Biotechnologie, immunologie, antibiorésistance, and commotions | 4 | 4 | 0 | 6 |
 | BforCure Advanced molecular analysis technologies to harness the power of the microbiota. To be more responsive, more efficient and make better decisions, BforCure allows public and industrial stakeholders to access biological information in real time, thanks to an innovative technology of rapid biodetection. | 2 | 0 | 1 | 36 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 19 | 11 | 6 | 57 |
 | Wespran Shaping the future of green biotech Wespran is a French climate deeptech startup specializing in synthetic biology and proteins. It is developing a turnkey biomimetic technology to upcycle industrial CO2 emissions into valuable products, starting with green methanol. At the forefront of biochemistry, physics, and bioinformatics, Wespran's clean biotechnology, FREED (Free Reactions using Enzymatic Electrocatalysis for Decarbonization), harnesses engineered enzymes. This innovative solution offers decarbonization as a service. By leveraging nature's power, Wespran helps industries reduce their carbon footprint while generating substantial profit. Target sectors include refineries, steel plants, chemical manufacturers, incinerators, cement factories, and thermal power plants. With a … Type: | 1 | 0 | 1 | 2 |
 | Faircraft Faircraft develops a highly sustainable, lab-grown alternative to animal leather. Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques. Tags: FrenchTech2030 Type: | 6 | 6 | 0 | 16 |
 | Tridek-One We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases Tridek-One is a spin-off from Inserm that develops first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of autoimmune and inflammatory diseases. The company primarily focuses on the research and development of first-in-class anti-CD31 agonistic modalities designed to restore the immune balance. Anti-CD31 agonistic mAbs have the potential to provide targeted immunomodulatory activity with a favorable safety profile in diseases with high unmet clinical need. Tridek-One has initiated a discovery program which targets another ITIM receptor, fully leveraging its understanding of inhibitory checkpoint receptor … Type: | 0 | 0 | 0 | 16 |
 | OncologyTube.com OncologyTube.com is a free video sharing website dedicated to helping oncology professionals spread knowledge about cancer research through video, audio Power Point and other multimedia. Watch and Share oncology and cancer interviews, symposiums, news and much more on OncologyTube.com Oncology News and Information Updated Daily, Cancer, Oncology, Video, and Social Media Type: | 12 | 0 | 13 | 2 |
 | DKMS UK Our mission is to provide a suitable donor for every person in need of a blood stem cell donation. Every 20 minutes, someone in the UK is diagnosed with a blood cancer like leukaemia, lymphoma and myeloma. For many, a blood stem cell donation from a matching donor is their best chance of survival. We work towards achieving our mission by raising awareness and empowering people to register as potential blood stem cell donors, and to join our campaign by taking action in their communities, schools, and companies; working with volunteers and organisations throughout the UK to inspire and register … Type: | 4 | 1 | 2 | 65 |
 | Thailand Center of Excellence for Life Sciences To make life science industry becomes top ten economy in Thailand with equitable access. Thailand Center of Excellence for Life Sciences (Public Organization) or TCELS was established in 2004 by the government of Thailand with the core intention of providing the central link between innovation and investment and facilitating domestic and international partnerships in life sciences business. It is a public organization and functions under the auspices of the Ministry of Higher Education, Sciences, Research and Innovation. With the team of experts, TCELS is ready to strategically captivate and streamline each emerging business opportunity in the life sciences industry in … Type: | 0 | 0 | 0 | 36 |
 | MRC Weatherall Institute of Molecular Medicine Leading Science for Better Health The MRC Weatherall Institute of Molecular Medicine is a world-leading biomedical research institute based in Oxford. Scientists working at the Institute are committed to improving our understanding of the processes underlying normal cell biology, and how these are perturbed in diseases which affect human health. The Institute, which benefits from strategic support from the Medical Research Council, houses an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the National Health Service and commercial companies with the aim of directly translating research outcomes into improving the … Type: | 5 | 1 | 4 | 77 |
 | European Cancer Organisation The European Cancer Organisation aims to reduce the burden of cancer, improving outcomes and the quality of care for cancer patients through multidisciplinarity and multiprofessionalism. As the not-for-profit federation of member organisations working in cancer at a European level, we convene oncology professionals and patients to agree policy, advocate for positive change and speak up for the European cancer community. Every year, we organise the European Cancer Summit. Multidisciplinary oncology, Oncopolicy, Public Affairs, European Cancer Societies, Promote cancer research, education, treatment and care, and Quality Cancer Care Type: | 21 | 5 | 19 | 68 |
 | Revance Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech Type: | 4 | 1 | 2 | 626 |
 | BioSpeedia BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur. BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, … Type: | 2 | 1 | 0 | 2 |
 | Koï Coaching | Accompagnement des créateurs d'entreprise [Automatic translation follows] 💥Professional coaching for business creators and entrepreneurs💥 Koï Coaching is the only one to have combined professional coaching and financial expertise in order to provide complete support for business creators and entrepreneurs. Specialist in supporting business creators, entrepreneurs and managers, people are at the heart of our concerns. Our approach is flexible, comprehensive and resolutely action-oriented. The Koï Coaching Team is guided by three watchwords: > Pragmatic > Human > Multidisciplinary Do not hesitate to call us for any additional questions! Team Koï Coaching professional coaching, financial expertise, support for business creation, training, law, taxation, web marketing, … Type: | 2 | 1 | 0 | 1 |
 | Europhartech - A Dômes Pharma Company [Automatic translation follows] Europhartech, a company of the Dômes Pharma Group Production site of the Dômes Pharma Group EUROPHARTECH is also a CMO (Contract Manufacturing Organization) for the Human and Veterinary Pharmaceutical Industry. Specialized in clinical batches, the production of dry forms and non-sterile liquid forms for human and veterinary use as well as in food supplements, complementary foods and medical devices. EUROPHARTECH also has solid expertise in the originator markets, ATU/AMM hospital and EHPAD unit BUD, PDA, generic and nutraceutical. EUROPHARTECH is a subsidiary of the DÔMES PHARMA Pharmaceutical Group historically specialized in Animal Health and present in Human … Type: | 2 | 1 | 0 | 74 |
 | Institut Bergonié [Automatic translation follows] Cancer Center of Nouvelle-Aquitaine #research #innovation #care #cancerprevention Founded in 1923, the Bergonié Institute has been a private healthcare institution of collective interest since May 20, 2010. It is also one of the 18 cancer centers. Located in the town of Bordeaux, it is the only cancer center in Nouvelle-Aquitaine and, with the Bordeaux University Hospital, constitutes the regional cancer center. The Bergonié Institute is labeled "integrated cancer research site" (SIRIC) by the National Cancer Institute (INCa). A member of the UNICANCER group, it is the bearer of a cancer model based on multidisciplinarity, individualization of treatments … Type: | 26 | 12 | 12 | 543 |
 | EcoMundo Our expertise, your global compliance Your go-to for regulatory guidance, excelling in global compliance and product stewardship. For over 2 decades, we've innovated to support a diverse clientele, from manufacturers to end users. Our arsenal? Cutting-edge software solutions and in-depth regulatory consulting. Dive into our database of global environmental regulations and steer through compliance complexities. Why EcoMundo? Because we're more than a service; we're a partner. With strong ties to regulatory authorities and a commitment to staying ahead of changes, we ensure you're always compliant, always competitive. Choose EcoMundo. Choose excellence, innovation, and a future-proof regulatory strategy. Environmental Services, Software … Type: | 6 | 2 | 6 | 176 |
 | Boltzmann We build machine learning applications for the core processes of your company. With our team of PhD-level data scientists we love to tackle challenging use cases centered on Machine Learning. Our main experience lies with ML R&D for innovative SMEs and accelerating ML tracks in corporates. Both challenging in their own way. Each time we focus on the ML part of the use case which typically result in plug-ins for existing workflows. We pride ourselves in communicating clearly about data and we love to train your budding data team and prepare them for handover. And with our own product Ludwig … Type: | 0 | 0 | 0 | 8 |
 | ProDigest SHIME technology & preclinical gastrointestinal expertise We are a dynamic pre-clinical CRO offering the best-in-class in vitro simulations of the gastrointestinal tract to (functional) food, feed and pharma industry. A strong team, the desire to innovate and our customers’ satisfaction are at the core of our DNA. Our long-standing expertise and tailormade solutions support your research from early phases to the final stages of product development. ProDigest is the company that brings on the market the SHIME® platform (Simulator of the Human Intestinal Microbial Ecosystem) and related technologies (Colon-on-a-plate®; Diamod®; MetaKey®) Gastrointestinal microbial ecology, Clinical trials, Molecular analyses, In vitro … Type: | 3 | 0 | 2 | 49 |
 | Confo Therapeutics Exploiting the conformational complexity of GPCRs to innovate drug discovery Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments. Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals … Type: | 0 | 0 | 0 | 69 |
 | OUAT! Humanizing the life science 4th industrial revolution with visual digital twins. OPERATIONAL EXCELLENCE. MADE SIMPLE. Our mission is to facilitate the digital transformation of the life sciences industry. At the time of a new industrial revolution, we are convinced that if factories must become smart and connected, the men and women remain the beating heart of production activities. To achieve this transformation for all and by all, it is necessary to rethink human-machine-data interactions. By leveraging intuitive 3D digital twin technologies, we empower the biopharmaceutical workforce to easily access data and optimize bioproduction processes from planning and simulation, to operators' … | 8 | 3 | 9 | 65 |
 | Andaman7 Next generation ePRO, RWE, virtual clinical trials, siteless trials... all that with a connected PHR for patients! Andaman7 is a patient driven mobile Personal Health Record and an intermediation platform to securely exchange health information with caregivers and researchers. We offer next generation trial recruiting and ePRO services to collect data remotely for life science companies, pharmaceutical companies and medical device manufacturers that need more and better patient outcomes and real world data for trials, market access and disease management. With our unique platform, you can achieve 3 goals at once: • Empowering patients • Managing diseases • Measuring outcomes … Type: | 12 | 4 | 6 | 24 |
 | MOLECUBES NV Making molecular imaging available to anyone. At MOLECUBES, we believe that molecular imaging should be accessible to every research lab. It is therefore our mission to lower the barrier to preclinical PET, SPECT and CT imaging by providing compact, intuitive, flexible benchtop imaging solutions with the highest performance, supported by fast and simple workflows. With more than 100 CUBES installed worldwide, MOLECUBES is a trusted partner by your side. At MOLECUBES we provide three separate benchtop imagers or “CUBES”: The γ-CUBE is our high-resolution, high-sensitivity micro-SPECT scanner using patented collimator design. The X-CUBE is our high-throughput micro-CT scanner allowing sub-minute … Type: | 3 | 1 | 1 | 26 |
 | Biocartis High precision diagnostics for personalized medicine Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. Our proprietary MDx IdyllaTM platform is a fully automated, real time system which offers accurate, highly-reliable molecular information from any biological sample in virtually any setting. IdyllaTM addresses the growing demand for personalized medicine by allowing fast and effective treatment selection and treatment progress monitoring. Biocartis is developing and marketing a rapidly expanding test menu addressing key unmet clinical needs with a focus in oncology, … Type: | 14 | 2 | 9 | 320 |
 | Osara Health The only clinically validated return to work intervention globally. Join us in transforming the care in cancer. Osara Health is transforming cancer care by empowering people and organizations affected by cancer to thrive. Using a combination of expertise, empathy and technology and access to digital tools, dedicated health coaching and evidence-based educational resources, Osara Health gives people impacted by cancer the opportunity to feel supported and informed. This puts them in control of their health outcomes and their holistic wellbeing. Formerly known as CancerAid, Osara Health was founded in 2016 by oncologists wanting to improve the cancer journey. The founding … Type: | 9 | 1 | 5 | 40 |
 | mySugr Make diabetes suck less. mySugr specializes in app-based, all-around care for people with diabetes made by people with diabetes. Our digital diabetes solution combines diabetes coaching, therapy management, diabetes supplies, automated data tracking, and seamless integration with a growing number of medical devices to ease the daily burden of living with diabetes. mySugr creates simple, effective solutions that serve people with diabetes, as well as organizations that manage populations with diabetes. diabetes, mobile technology, digital health, and population health Type: | 8 | 1 | 3 | 145 |
 | VALANX Biotech Full flexibility in conjugation site selection | Never worry about your conjugation process again | CHO & E. coli | ADCs Partner with us and leverage our technology for the development of the next wave of superior protein conjugates and Antibody-Drug-Conjugates! Looking to fast track your development of next generation bioconjugates, staying ahead of your competitors? With the complete freedom to choose where on the protein, we conjugate and optimize for: • Stability, • Aggregation, • Superior efficacy, • Therapeutic window ... and more! The process is simple! 1. Get in touch with us (message us here or visit our … Tags: H2020 Type: | 3 | 1 | 3 | 12 |
 | BioNTech R&D (Austria) GmbH Subsidiary of BioNTech SE, now trading as BioNTech R&D (Austria). Developing novel anti-bacterials. BioNTech R&D Austria GmbH (formerly: PhagoMed Biopharma GmbH) is a fully owned subsidiary of BioNTech. The team in Vienna focuses on developing novel anti-bacterial drugs for persistent bacterial infections. Biotech Type: | 2 | 0 | 1 | 7 |
 | BIOMAKERS Medicina Genómica de Precisión y Plataformas Biotecnológicas de Análisis Genómicos & Big Data en cáncer y rare diseases BIOMAKERS is a global Precision Medicine Company that produces complex & advanced genomic data + RWE to make cancer patients live longer and transform oncology data-driven Drug Development globally. having built an unprecedented platform that enables Diagnosis, Treatment, Drug Development, Target discovery and AI for Cancer and Rare Diseases, having developed genomic products in the 4 Stages of the Biopharmaceutical chain and providing the largest LATAM genomic representation in the global Oncology Drug Development Landscape. BIOMAKERS provides extensive genomic and molecular Testing … Type: | 5 | 0 | 5 | 69 |
 | Orio Therapeutics At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the … Type: | 1 | 0 | 0 | 1 |
 | Theolytics Transforming patients’ lives | Through world leading science | With a great team Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development. Biotech, Oncology, and Virology | 3 | 2 | 1 | 28 |
 | Sano Genetics Accelerating the world's transition to precision medicine. At Sano, our mission is to accelerate the world's transition to precision medicine. Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients. Genetics, Big Data, and Research Type: | 5 | 2 | 1 | 84 |
 | Life Science People Our mission at Life Science People is to make a tangible contribution to global health. Talent experts providing scalable, bespoke recruitment solutions for growing Life Science companies. We have experienced teams of recruiters who can advise and hire across all areas within: • Pharmaceutical • Biotechnology • CRO Services • Health Technology • Medical Devices Our services include contingent, retained, and embedded services, our own version of scaled RPO – suited to rapidly growing organisations. We also offer an investment platform, allowing fledgling SME’s access to our large network of qualified investors, VC’s and PE’s. We recruit extensively across APAC, … Type: | 0 | 0 | 0 | 88 |
 | Pelago Bioscience AB Pelago Bioscience At Pelago Bioscience, we’re here to help you make faster, better-informed decisions in drug discovery. In 2010, our founders began to develop our proprietary CETSA® (Cellular Thermal Shift Assay) technology, publishing a seminal research paper in Science 2013. Since then, Pelago Bioscience has become the leading CRO providing actionable, biologically relevant insights at the pre-clinical stage.Unlike traditional methods, CETSA gives you a reliable picture of drug-target interactions, ensuring that what you see in cells translates to patients. Our services rest on four pillars: • Certainty in Biological Relevance: CETSA’s physiological approach helps minimize late-stage risks. • Fast & … Type: | 3 | 0 | 2 | 60 |
 | IO Biotech Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has … Type: | 0 | 0 | 0 | 89 |
 | Merus N.V. Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways. Working at Merus offers opportunity to grow and develop a career that offers both individual and company success. You have the chance to make an impact within the oncology field by being part of the development of … Type: | 0 | 0 | 0 | 267 |
 | ENOUGH Making More with Less ENOUGHs purpose to ‘make protein sustainable’. Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet. ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is versatile and can be made into alternative/vegan meat, seafood and dairy products. The company will supply ABUNDA as a B2B (business to business) food ingredient to consumer brands and retailers, addressing the need for high scale supply of healthy and sustainable protein to address a rapidly … Type: | 4 | 2 | 1 | 93 |
 | Doklog [Automatic translation follows] Create your health communication platform Your health information network. Platform intended for all health stakeholders: professionals, patients, establishments, associations, authorities, manufacturers, etc.). health, social media, hcsmeufr, and startup Type: | 1 | 0 | 0 | 0 |
 | ErVimmune Targeting shared unconventional tumor antigens in cancer immunotherapy R&D oncology | 7 | 3 | 5 | 17 |
 | REGEnLIFE Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, … Type: | 23 | 3 | 14 | 12 |
 | Mabylon AG Unique know-how to discover and engineer novel antibody therapeutics in allergy, inflammation and neurology. Mabylon AG, a private Swiss biotech company, is leading innovation in antibody-based treatments for severe allergies, inflammation, and neurological disorders. Our B-cell screening platform identifies natural human antibodies with high specificity and therapeutic potential. MY006, our first-in-class multispecific antibody therapeutic for peanut allergy, is tackling the growing food allergy market. Type: | 1 | 0 | 1 | 20 |
 | Minos Biosciences Revolutionary single-cell analysis solution for fundamental, applied and clinical research and diagnostic. Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in single-cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. Type: | 11 | 2 | 11 | 14 |
 | C4Diagnostics Infectious diseases revealed C4Diagnostics is a French-based biotech specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases C4Diagnostics' strategy for the better management of Human infectious diseases, is to develop game changing IVD tests which are significantly faster than standard methods whilst maintaining comparable or better performance. Its portfolio currently focuses on the diagnosis of Covid-19 (C4Covid-19), Legionnaires’ Disease (C4Legio LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). C4Diagnostics also has a business unit dedicated to environmental diagnostics, called C4Environment. It provides services for the detection of SARS-CoV-2 and other … Type: | 5 | 2 | 2 | 2 |
 | BIOINSPIR [Automatic translation follows] Products from ecological chemistry BIOINSPIR's mission is to make clean chemistry the new standard. At BIOINSPIR we synthesize biosourced molecules with high added value and the lowest possible environmental impact. Our ecocatalysts® are of plant origin: they are derived from the transformation of plant species that naturally accumulate the metals present in their environment. molecules, biosourced, biosource, bioinspiration, bioinspired, biomimicry, cosmetics, chemistry, plant chemistry, fine chemistry, green chemistry, ecology, decontamination, plants, ecocatalysis, and ecocatalyst Type: | 19 | 4 | 18 | 6 |
 | AgenT Detect Alzheimer's earlier, when it could be prevented AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing accurate blood diagnoses and the next generation of precision therapies to treat Alzheimer’s. ALzheimer's disease, Biotechnology, Diagnosis, Machine learning, and AI Type: | 11 | 3 | 6 | 33 |
 | AdhexPharma We deliver solutions AdhexPharma is an independent drug delivery company specialized in Transdermal & Topical patches and Oral Thin Films technologies. AdhexPharma is based in France, with GMP manufacturing facility for European and US market. We have 4 approved products in Europe and North America and a pipeline of 6 candidates, ranging from 505(b)2 / NDA and ANDA in different therapeutical areas: pain, CNS, anesthesia, smoking cessation and HRT. Trandermal, Patch, Oral Thin Film, Drug Development, GMP manufacturing, FDA approved, OTF, ODF, cGMP, TDS, CDMO, and CMO Type: | 8 | 2 | 4 | 128 |
 | Abolis Biotechnologies Decipher - Innovate - Build Abolis is a French company delivering high-impact innovations in biotechnologies that supports industries in their transition to build a better future in collaboration with Nature. We provide tailor-made industrial solutions based on micro-organisms. Founded in 2014, Abolis is made up of a team of over 54 people, sharing a scientific and humanist ambition. Determined to become a key player in the transformation of manufacturing, we combine our expertise in biology, fermentation, IT, robotics, analytics and industrial property to reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals. We help industries … Type: | 18 | 6 | 14 | 42 |
 | TômTex Inc. Designing sustainable materials for the future TômTex is a leading material science company dedicated to developing a cutting-edge platform technology for creating sustainable textiles sourced directly from waste materials, not fossil fuels. We are building 100% bio-based material that is plastic-free, petro-free and 100% naturally biodegradable without toxic chemical. TômTex Series M ® (Mushroom Chitosan) 100% Plant based TômTex Series WS ® (Waste Shell Seafood Chitosan) 100% bio based At TômTex, our mission is to create innovative material designs that parallel lifecycles observed in nature and serve as alternatives to the production methods that have contributed to our world’s environmental … Type: | 0 | 0 | 0 | 16 |
 | UQ Queensland Brain Institute Our scientists work to understand the development, organisation and function of the brain in health and disease. The Queensland Brain Institute, at The University of Queensland, works to understand the development, organisation and function of the brain. We aim to understand the neural circuits in the brain, how their function results in behavioural outcomes, and how dysfunction of these circuits leads to disorders such as dementia, Parkinson’s disease and schizophrenia. We aim to: 1. Develop novel therapeutic approaches to treat disorders of neural function and 2. Use our understanding of brain function to improve learning in classrooms and in the … Type: | 7 | 0 | 2 | 199 |
 | Association of European Cancer Leagues Making a difference in cancer control in Europe since 1980 The Association of European Cancer Leagues (ECL) is a non-profit, pan-European umbrella organisation of national and regional cancer societies. Located in Brussels, ECL provides an exclusive platform for members to collaborate with their international peers, primarily in the areas of cancer prevention, tobacco control, access to medicines and patient support, and creates opportunities to advocate for these issues at the EU level. ECL’s VISION: A Europe free of cancers. ECL’s MISSION: To advocate for improved cancer control and care in Europe through facilitating collaboration between cancer leagues , and influencing … Type: | 8 | 1 | 7 | 40 |
Startup